{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:41:02Z","timestamp":1790815262282,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Training Project for Leading Talents of the Health and Family Planning Commission of Yunnan Province","award":["L-201624"],"award-info":[{"award-number":["L-201624"]}]},{"name":"Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases open project","award":["DKME202218"],"award-info":[{"award-number":["DKME202218"]}]},{"name":"Yunnan Clinical Medical Research Center open project","award":["N2020LCZXKF-NM06"],"award-info":[{"award-number":["N2020LCZXKF-NM06"]}]},{"name":"Special Project for \u201cFamous Doctor\u201d of Yunnan Ten Thousand Talents Plan","award":["YNWR-MY-2019-020"],"award-info":[{"award-number":["YNWR-MY-2019-020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01679-1","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T04:02:06Z","timestamp":1723435326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lipid profile alterations and biomarker identification in type 1 diabetes mellitus patients under glycemic control"],"prefix":"10.1186","volume":"24","author":[{"given":"Yunying","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"1679_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1117076","volume":"14","author":"EW Brenu","year":"2023","unstructured":"Brenu EW, Harris M, Hamilton-Williams EE. Circulating biomarkers during progression to type 1 diabetes: a systematic review. Front Endocrinol. 2023;14: 1117076.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1679_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98.","journal-title":"Health Promot Perspect"},{"issue":"7","key":"1679_CR3","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.2337\/diacare.26.7.2194","volume":"26","author":"AD Association","year":"2003","unstructured":"Association AD. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care. 2003;26(7):2194\u20137.","journal-title":"Diabetes Care"},{"key":"1679_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1399-5448.2009.00568.x","volume":"10","author":"ME Craig","year":"2009","unstructured":"Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10:3\u201312.","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"1679_CR5","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.2337\/dc07-0282","volume":"30","author":"K Raile","year":"2007","unstructured":"Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care. 2007;30(10):2523\u20138.","journal-title":"Diabetes Care"},{"issue":"11","key":"1679_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa2210834","volume":"388","author":"RP Wadwa","year":"2023","unstructured":"Wadwa RP, Reed ZW, Buckingham BA, DeBoer MD, Ekhlaspour L, Forlenza GP, Schoelwer M, Lum J, Kollman C, Beck RW. Trial of hybrid closed-loop control in young children with type 1 diabetes. N Engl J Med. 2023;388(11):991\u20131001.","journal-title":"N Engl J Med"},{"issue":"2","key":"1679_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018;6(2):122\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1679_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41574-023-00837-0","volume":"19","author":"D Tatovic","year":"2023","unstructured":"Tatovic D, Narendran P, Dayan CM. A perspective on treating type 1 diabetes mellitus before insulin is needed. Nat Rev Endocrinol. 2023;19(6):361\u201370.","journal-title":"Nat Rev Endocrinol"},{"key":"1679_CR9","doi-asserted-by":"publisher","first-page":"101235","DOI":"10.1016\/j.plipres.2023.101235","volume":"91","author":"V Petrenko","year":"2023","unstructured":"Petrenko V, Sinturel F, Riezman H, Dibner C. Lipid metabolism around the body clocks. Prog Lipid Res. 2023;91:101235.","journal-title":"Prog Lipid Res"},{"issue":"13","key":"1679_CR10","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1084\/jem.20081800","volume":"205","author":"M Oresic","year":"2008","unstructured":"Oresic M, Simell S, Sysi-Aho M, Nanto-Salonen K, Seppanen-Laakso T, Parikka V, Katajamaa M, Hekkala A, Mattila I, Keskinen P. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008;205(13):2975\u201384.","journal-title":"J Exp Med"},{"issue":"11","key":"1679_CR11","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.2337\/db10-1652","volume":"60","author":"M Pflueger","year":"2011","unstructured":"Pflueger M, Sepp\u00e4nen-Laakso T, Suortti T, Hy\u00f6tyl\u00e4inen T, Achenbach P, Bonifacio E, Ore\u0161i\u010d M, Ziegler AG. Age-and islet autoimmunity\u2013associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes. 2011;60(11):2740\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"1679_CR12","doi-asserted-by":"publisher","first-page":"10635","DOI":"10.1038\/s41598-018-28907-8","volume":"8","author":"S Lamichhane","year":"2018","unstructured":"Lamichhane S, Ahonen L, Dyrlund T. Dynamics of plasma lipidome in progression to islet autoimmunity and type 1 diabetes\u2013type 1 diabetes prediction and prevention study (DIPP). Sci Rep. 2018;8(1):10635.","journal-title":"Sci Rep"},{"key":"1679_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110578","volume":"197","author":"J Julve","year":"2023","unstructured":"Julve J, Genua I, Quifer-Rada P, Yanes \u00d3, Barranco-Altirriba M, Hern\u00e1ndez M, Junza A, Capellades J, Granado-Casas M, Alonso N. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. Diabetes Res Clin Pract. 2023;197: 110578.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"1679_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/met.2019.0038","volume":"17","author":"A Parker","year":"2019","unstructured":"Parker A, Kim Y. The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2019;17(8):389\u201396.","journal-title":"Metab Syndr Relat Disord"},{"issue":"43","key":"1679_CR15","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.0705894104","volume":"104","author":"JM Wenzlau","year":"2007","unstructured":"Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci. 2007;104(43):17040\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"1679_CR16","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2337\/db13-1775","volume":"63","author":"H Kallionp\u00e4\u00e4","year":"2014","unstructured":"Kallionp\u00e4\u00e4 H, Elo LL, Laajala E, Mykk\u00e4nen J, Rica\u00f1o-Ponce I, Vaarma M, Laajala TD, Hy\u00f6ty H, Ilonen J, Veijola R. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes. 2014;63(7):2402\u201314.","journal-title":"Diabetes"},{"issue":"6","key":"1679_CR17","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2337\/db14-0983","volume":"64","author":"R Moulder","year":"2015","unstructured":"Moulder R, Bhosale SD, Erkkil\u00e4 T, Laajala E, Salmi J, Nguyen EV, Kallionp\u00e4\u00e4 H, Mykk\u00e4nen J, V\u00e4h\u00e4-M\u00e4kil\u00e4 M, Hy\u00f6ty H. Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility. Diabetes. 2015;64(6):2265\u201378.","journal-title":"Diabetes"},{"issue":"1","key":"1679_CR18","doi-asserted-by":"publisher","DOI":"10.15280\/jlm.2014.4.1.17","volume":"4","author":"Z Wu","year":"2014","unstructured":"Wu Z, Shon JC, Liu KH. Mass spectrometry-based lipidomics and its application to biomedical research. J Lifestyle Med. 2014;4(1): 17.","journal-title":"J Lifestyle Med"},{"issue":"6","key":"1679_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1194\/jlr.R300004-JLR200","volume":"44","author":"X Han","year":"2003","unstructured":"Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res. 2003;44(6):1071\u20139.","journal-title":"J Lipid Res"},{"issue":"12","key":"1679_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003451","volume":"17","author":"H Yun","year":"2020","unstructured":"Yun H, Sun L, Wu Q, Zong G, Qi Q, Li H, Zheng H, Zeng R, Liang L, Lin X. Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China. PLoS Med. 2020;17(12): e1003451.","journal-title":"PLoS Med"},{"issue":"13","key":"1679_CR21","doi-asserted-by":"publisher","first-page":"e126925","DOI":"10.1172\/jci.insight.126925","volume":"4","author":"WS Chew","year":"2019","unstructured":"Chew WS, Torta F, Ji S, Choi H, Begum H, Sim X, Khoo CM, Khoo EYH, Ong WY, Van Dam RM. Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence. JCI insight. 2019;4(13):e126925.","journal-title":"JCI insight"},{"issue":"9","key":"1679_CR22","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","volume":"18","author":"L Wigger","year":"2017","unstructured":"Wigger L, Cruciani-Guglielmacci C, Nicolas A, Denom J, Fernandez N, Fumeron F, Marques-Vidal P, Ktorza A, Kramer W, Schulte A. Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans. Cell Rep. 2017;18(9):2269\u201379.","journal-title":"Cell Rep"},{"issue":"1","key":"1679_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13098-023-01120-y","volume":"15","author":"A Kamrul-Hasan","year":"2023","unstructured":"Kamrul-Hasan A, Talukder SK, Kabir MA, Mustari M, Un Nabi MM, Gaffar AJ, Hossain MF, Alam MS, Islam MR, Hannan MA. Comparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh. Diabetol Metab Syndr. 2023;15(1):139.","journal-title":"Diabetol Metab Syndr"},{"key":"1679_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40618-014-0115-4","volume":"37","author":"L Ji","year":"2014","unstructured":"Ji L, Weng J, Lu J, Guo X, Yang W, Jia W, Zou D, Zhou Z, Zhu D, Ji Q. Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in China. J Endocrinol Invest. 2014;37:843\u201352.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1679_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226(1):497\u2013509.","journal-title":"J Biol Chem"},{"key":"1679_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-017-1304-x","volume":"14","author":"J Tu","year":"2018","unstructured":"Tu J, Yin Y, Xu M, Wang R, Zhu ZJ. Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain. Metabolomics. 2018;14:1\u201311.","journal-title":"Metabolomics"},{"issue":"1","key":"1679_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal T, Castillo S, Villar-Briones A, Ore\u0161i\u010d M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010;11(1):1\u201311.","journal-title":"BMC Bioinformatics"},{"issue":"16","key":"1679_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20164049","volume":"20","author":"MJ Meneses","year":"2019","unstructured":"Meneses MJ, Silvestre R, Sousa-Lima I, Macedo MP. Paraoxonase-1 as a regulator of glucose and lipid homeostasis: impact on the onset and progression of metabolic disorders. Int J Mol Sci. 2019;20(16): 4049.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1679_CR29","doi-asserted-by":"publisher","first-page":"158823","DOI":"10.1016\/j.bbalip.2020.158823","volume":"1866","author":"AI Sobczak","year":"2021","unstructured":"Sobczak AI, Pitt SJ, Smith TK, Ajjan RA, Stewart AJ. Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(1):158823.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1679_CR30","doi-asserted-by":"publisher","first-page":"1 \u20139 %@ 1534\u201348","DOI":"10.1007\/s11892-020-01326-8","volume":"20","author":"T Suvitaival","year":"2020","unstructured":"Suvitaival T. Lipidomic abnormalities during the pathogenesis of type 1 diabetes: a quantitative review. Curr Diabetes Rep. 2020;20:1-9 %@ 1534-4827.","journal-title":"Curr Diabetes Rep"},{"key":"1679_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155247","volume":"134","author":"D Tric\u00f2","year":"2022","unstructured":"Tric\u00f2 D, Mengozzi A, Baldi S, Bizzotto R, Olaniru O, Toczyska K, Huang GC, Seghieri M, Frascerra S, Amiel SA. Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals. Metabolism. 2022;134: 155247.","journal-title":"Metabolism"},{"issue":"6","key":"1679_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tem.2020.01.015","volume":"31","author":"B Verg\u00e8s","year":"2020","unstructured":"Verg\u00e8s B. Dyslipidemia in type 1 diabetes: a masked danger. Trends Endocrinol Metab. 2020;31(6):422\u201334.","journal-title":"Trends Endocrinol Metab"},{"key":"1679_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Sun B, Huang S, Zhu C, Bian M. Glycemic variability: adverse clinical outcomes and how to improve it? Cardiovasc Diabetol. 2020;19:1\u201314.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1679_CR34","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/JME-16-0249","volume":"58","author":"RH Ritchie","year":"2017","unstructured":"Ritchie RH, Zerenturk EJ, Prakoso D, Calkin AC. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy. J Mol Endocrinol. 2017;58(4):R225\u201340.","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"1679_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.diabet.2009.04.004","volume":"35","author":"B Verg\u00e8s","year":"2009","unstructured":"Verg\u00e8s B. Lipid disorders in type 1 diabetes. Diabetes Metab. 2009;35(5):353\u201360.","journal-title":"Diabetes Metab"},{"issue":"4","key":"1679_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/joim.12026","volume":"273","author":"VP M\u00e4kinen","year":"2013","unstructured":"M\u00e4kinen VP, Soininen P, Kangas AJ, Forsblom C, Tolonen N, Thorn L, Viikari J, Raitakari O, Savolainen M, Groop PH. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane study. J Intern Med. 2013;273(4):383\u201395.","journal-title":"J Intern Med"},{"issue":"2","key":"1679_CR37","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.ki.5000021","volume":"69","author":"J Lin","year":"2006","unstructured":"Lin J, Hu FB, Rimm EB, Rifai N, Curhan GC. The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int. 2006;69(2):336\u201342.","journal-title":"Kidney Int"},{"issue":"2","key":"1679_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/dc10-0793","volume":"34","author":"MB Sasongko","year":"2011","unstructured":"Sasongko MB, Wong TY, Nguyen TT, Kawasaki R, Jenkins A, Shaw J, Wang JJ. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care. 2011;34(2):474\u20139.","journal-title":"Diabetes Care"},{"issue":"1\u20132","key":"1679_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbalip.2004.09.003","volume":"1686","author":"G Liebisch","year":"2004","unstructured":"Liebisch G, Lieser B, Rathenberg J, Drobnik W, Schmitz G. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta Mol Cell Biol Lipids. 2004;1686(1\u20132):108\u201317.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"1679_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1096\/fasebj.13.1.135","volume":"13","author":"CLE Yen","year":"1999","unstructured":"Yen CLE, Mar MH, Zeisel SH. Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase. FASEB J. 1999;13(1):135\u201342.","journal-title":"FASEB J"},{"issue":"2","key":"1679_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrendo.2016.169","volume":"13","author":"PJ Meikle","year":"2017","unstructured":"Meikle PJ, Summers SA. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat Rev Endocrinol. 2017;13(2):79\u201391.","journal-title":"Nat Rev Endocrinol"},{"issue":"47","key":"1679_CR42","doi-asserted-by":"publisher","first-page":"36596","DOI":"10.1074\/jbc.M006924200","volume":"275","author":"PG Yancey","year":"2000","unstructured":"Yancey PG, de la Llera-Moya M, Swarnakar S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Williams DL, Rothblat GH. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem. 2000;275(47):36596\u2013604.","journal-title":"J Biol Chem"},{"issue":"3","key":"1679_CR43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jacl.2019.02.004","volume":"13","author":"E Zakiev","year":"2019","unstructured":"Zakiev E, Rached F, Lhomme M, Darabi-Amin M, Ponnaiah M, Becker PH, Therond P, Serrano CV Jr, Santos RD, Chapman MJ. Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein AI deficiency. J Clin Lipidol. 2019;13(3):468-480. e468.","journal-title":"J Clin Lipidol"},{"issue":"16","key":"1679_CR44","doi-asserted-by":"publisher","first-page":"e138034","DOI":"10.1172\/jci.insight.138034","volume":"5","author":"AJ Nelson","year":"2020","unstructured":"Nelson AJ, Stephenson DJ, Bone RN, Cardona CL, Park MA, Tusing YG, Lei X, Kokotos G, Graves CL, Mathews CE. Lipid mediators and biomarkers associated with type 1 diabetes development. JCI Insight. 2020;5(16):e138034.","journal-title":"JCI Insight"},{"issue":"2","key":"1679_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00125-017-4462-5","volume":"61","author":"A Szpigel","year":"2018","unstructured":"Szpigel A, Hainault I, Carlier A, Venteclef N, Batto AF, Hajduch E, Bernard C, Ktorza A, Gautier JF, Ferr\u00e9 P. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes. Diabetologia. 2018;61(2):399\u2013412.","journal-title":"Diabetologia"},{"issue":"5","key":"1679_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051835","volume":"21","author":"A Poznyak","year":"2020","unstructured":"Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus\u2013atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5): 1835.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1679_CR47","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1111\/dom.15264","volume":"25","author":"J Brandts","year":"2023","unstructured":"Brandts J, Tittel SR, Bramlage P, Danne T, Brix JM, Zimny S, Heyer CH, Holl RW, M\u00fcller-Wieland D. L ow-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: lipid goal attainment in a large German-Austrian diabetes registry. Diabetes Obes Metab. 2023;25(12):3700\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1679_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-023-01007-y","volume":"15","author":"MTK Toyoshima","year":"2023","unstructured":"Toyoshima MTK, Santana MF, Silva AR, Mello GB, Santos-Bezerra DP, Goes MF, Bosco AA, Caramelli B, Ronsein GE, Correa-Giannella ML. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case\u2013control study. Diabetol Metab Syndr. 2023;15(1):42.","journal-title":"Diabetol Metab Syndr"},{"key":"1679_CR49","doi-asserted-by":"publisher","unstructured":"Della Pepa G, Lupoli R, Masulli M, Boccia R, De Angelis R, Gianfrancesco S, Piccolo R, Rainone C, Rivellese AA, Annuzzi G, Bozzetto L. Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes. J Endocrinol Invest. 2024:1\u20138. https:\/\/doi.org\/10.1007\/s40618-024-02333-2.","DOI":"10.1007\/s40618-024-02333-2"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01679-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T16:03:00Z","timestamp":1723478580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01679-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1679"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01679-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was conducted in accordance with the regulations of the Medical Ethics Committee of the First People\u2019s Hospital of Yunnan Province (No. KHLL2016-KY038). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}